Therapeutic development in the absence of predictive animal models of nervous system disorders proceedings of a workshop
Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most CNS drugs fail because of efficacy, and the core issue underlying these problems is a poor understanding of disease biology. Concern about t...
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Washington, DC
The National Academies Press
2017, [2017]
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references